Northwestern University Human Resources

Northwestern University Human Resources logo
🇺🇸United States
Ownership
Private
Established
1851-01-28
Employees
5K
Market Cap
-
Website
https://www.venturecat.northwestern.edu

Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy

Withdrawn
Conditions
First Posted Date
2004-05-17
Last Posted Date
2012-04-25
Lead Sponsor
Northwestern University
Registration Number
NCT00083044
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

🇺🇸

Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, Alabama, United States

Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

Phase 3
Completed
Conditions
First Posted Date
2004-05-03
Last Posted Date
2012-06-06
Lead Sponsor
Northwestern University
Target Recruit Count
35
Registration Number
NCT00004230
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

Phase 1
Completed
Conditions
First Posted Date
2004-04-28
Last Posted Date
2013-07-10
Lead Sponsor
Northwestern University
Target Recruit Count
30
Registration Number
NCT00004174
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer

Phase 2
Terminated
Conditions
First Posted Date
2004-04-19
Last Posted Date
2012-06-06
Lead Sponsor
Northwestern University
Registration Number
NCT00005608
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy

Phase 3
Completed
Conditions
First Posted Date
2004-04-12
Last Posted Date
2012-06-06
Lead Sponsor
Northwestern University
Registration Number
NCT00004166
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer

Phase 2
Terminated
Conditions
First Posted Date
2004-03-25
Last Posted Date
2012-06-11
Lead Sponsor
Northwestern University
Registration Number
NCT00006262
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer

First Posted Date
2004-03-16
Last Posted Date
2011-02-21
Lead Sponsor
Northwestern University
Target Recruit Count
40
Registration Number
NCT00004909
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

First Posted Date
2004-03-16
Last Posted Date
2012-06-01
Lead Sponsor
Northwestern University
Registration Number
NCT00004913
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

🇺🇸

Indiana University Cancer Center, Indianapolis, Indiana, United States

🇺🇸

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease

Phase 2
Terminated
Conditions
First Posted Date
2004-03-04
Last Posted Date
2012-06-11
Lead Sponsor
Northwestern University
Target Recruit Count
2
Registration Number
NCT00005595
Locations
🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath